Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for women
- PMID: 22076307
- DOI: 10.1097/gme.0b013e318230e286
Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for women
Abstract
Objective: Little is known about the natural history of hypoactive sexual desire disorder (HSDD). We examined the sociodemographic, relationship, help seeking, sexual function, and medical characteristics of women with a clinical diagnosis of generalized, acquired HSDD by menopause status.
Methods: This study was a cross-sectional baseline data analysis from the HSDD Registry for Women (N = 1,574, from 33 US clinical sites). HSDD was clinically diagnosed and confirmed. Validated measures of sexual function, relationship factors, and health, as well as newly developed questions on help seeking were assessed using the questionnaire.
Results: Participants were predominantly married or living with a partner (81.7%) and represented a range of race/ethnic backgrounds and ages (mean ± SD, 42.9 ± 11.9 y). Most (56.8%) described their HSDD severity as "moderate to severe," with 26.5% rating the problem severe. Nonetheless, most women (69.8%) reported being happy in their relationship, and 61.8% were satisfied with their partner communication. Postmenopausal women had lower Female Sexual Function Index total scores, indicating worse sexual function (14.0 ± 7.5) than premenopausal women (16.7 ± 6.8, P < 0.001), although both groups had similarly low scores on the sexual desire domain (3.4 ± 1.3 vs 3.3 ± 1.4). Less than half of the overall sample had sought professional help, among whom hormonal treatments had been used by 23.7% of postmenopausal women and by 7.6% of premenopausal women.
Conclusions: Most women with HSDD were in long-term partner relationships with high levels of overall relationship satisfaction. Postmenopausal women were more likely to seek help for their disorder, despite similarly high levels of distress associated with HSDD. Further research is needed to examine treatment outcomes.
Comment in
-
The Hypoactive Sexual Desire Disorder Registry to characterize the natural history and outcomes of women with hypoactive sexual desire disorder.Menopause. 2012 Apr;19(4):379-81. doi: 10.1097/gme.0b013e3182498c7e. Menopause. 2012. PMID: 22453129 No abstract available.
-
Re: Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for women.J Urol. 2012 Aug;188(2):548-9. doi: 10.1016/j.juro.2012.03.101. Epub 2012 Jun 15. J Urol. 2012. PMID: 22784748 No abstract available.
Similar articles
-
Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS).Menopause. 2006 Jan-Feb;13(1):46-56. doi: 10.1097/01.gme.0000172596.76272.06. Menopause. 2006. PMID: 16607098
-
Depression in premenopausal women with HSDD: baseline findings from the HSDD Registry for Women.Psychosom Med. 2012 Apr;74(3):305-11. doi: 10.1097/PSY.0b013e31824c4c89. Epub 2012 Mar 20. Psychosom Med. 2012. PMID: 22434918
-
Sexual arousal and lubrication problems in women with clinically diagnosed hypoactive sexual desire disorder: preliminary findings from the hypoactive sexual desire disorder registry for women.J Sex Marital Ther. 2012;38(1):41-62. doi: 10.1080/0092623X.2011.569642. J Sex Marital Ther. 2012. PMID: 22268981
-
Low sexual desire--is it all in her head? Pathophysiology, diagnosis, and treatment of hypoactive sexual desire disorder.Postgrad Med. 2010 Nov;122(6):128-36. doi: 10.3810/pgm.2010.11.2230. Postgrad Med. 2010. PMID: 21084789 Review.
-
The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.J Sex Med. 2008 Sep 2;5 Suppl 4:182-93; quiz 193. doi: 10.1111/j.1743-6109.2008.00961.x. J Sex Med. 2008. PMID: 18783534 Review.
Cited by
-
Bremelanotide for Treatment of Female Hypoactive Sexual Desire.Neurol Int. 2022 Jan 4;14(1):75-88. doi: 10.3390/neurolint14010006. Neurol Int. 2022. PMID: 35076581 Free PMC article. Review.
-
Female Sexual Health: Barriers to Optimal Outcomes and a Roadmap for Improved Patient-Clinician Communications.J Womens Health (Larchmt). 2019 Apr;28(4):432-443. doi: 10.1089/jwh.2018.7352. Epub 2019 Feb 4. J Womens Health (Larchmt). 2019. PMID: 30714849 Free PMC article.
-
The Prevalence of Sexual Dysfunction in the Different Menopausal Stages: A Systematic Review and Meta-Analysis.Int J Sex Health. 2021 Jul 12;33(3):439-472. doi: 10.1080/19317611.2021.1926039. eCollection 2021. Int J Sex Health. 2021. PMID: 38595744 Free PMC article.
-
Efficacy of Hormonal and Nonhormonal Approaches to Vaginal Atrophy and Sexual Dysfunctions in Postmenopausal Women: A Systematic Review.Rev Bras Ginecol Obstet. 2022 Oct;44(10):986-994. doi: 10.1055/s-0042-1756148. Epub 2022 Nov 29. Rev Bras Ginecol Obstet. 2022. PMID: 36446564 Free PMC article.
-
Impact of estrogens in males and androgens in females.J Clin Invest. 2019 May 1;129(5):1818-1826. doi: 10.1172/JCI125755. Epub 2019 May 1. J Clin Invest. 2019. PMID: 31042159 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical